Article
Role of Asparagine Endopeptidase in Mediating Wild-Type p53 Inactivation of Glioblastoma
24 Jul 2019
Abstract excerpt
BACKGROUND: Isocitrate dehydrogenase wild-type (WT) glioblastoma (GBM) accounts for 90% of all GBMs, yet only 27% of isocitrate dehydrogenase WT-GBMs have p53 mutations. However, the tumor surveillance function of WT-p53 in GBM is subverted by mechanisms that are not fully understood. METHODS: We investigated the proteolytic inactivation of WT-p53 by asparaginyl endopeptidase (AEP) and its effects on GBM...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
